{"version":"1.0","provider_name":"Group Action Lawyers","provider_url":"https:\/\/www.groupactionlawyers.co.uk\/blog","author_name":"Author","author_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt","title":"Lynparza Cancer Drug Recall Confirmed By UK Regulators","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7LyB9AQJ4X\"><a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/lynparza-cancer-drug-recall-confirmed-by-uk-regulators\">Cancer drug recall confirmed by UK regulators<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/lynparza-cancer-drug-recall-confirmed-by-uk-regulators\/embed#?secret=7LyB9AQJ4X\" width=\"600\" height=\"338\" title=\"&#8220;Cancer drug recall confirmed by UK regulators&#8221; &#8212; Group Action Lawyers\" data-secret=\"7LyB9AQJ4X\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall-facebook.png?fit=1200%2C630&ssl=1","thumbnail_width":"1200","thumbnail_height":"630","description":"A Class 3 recall has been initiated for Lynparza capsule (50mg) due to reports of excessive levels of an active ingredient used in the drug. AstraZeneca UK has initiated the cancer drug recall, primarily for batch NG327."}